Vanguard Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.95B | Buy |
9,424,048
+16,157
| +0.2% | +$8.48M | 0.08% | 246 |
|
2025
Q1 | $5.97B | Buy |
9,407,891
+121,545
| +1% | +$77.1M | 0.11% | 165 |
|
2024
Q4 | $6.61B | Sell |
9,286,346
-33,944
| -0.4% | -$24.2M | 0.12% | 149 |
|
2024
Q3 | $9.8B | Buy |
9,320,290
+326,320
| +4% | +$343M | 0.18% | 96 |
|
2024
Q2 | $9.45B | Buy |
8,993,970
+63,729
| +0.7% | +$67M | 0.18% | 95 |
|
2024
Q1 | $8.6B | Buy |
8,930,241
+91,956
| +1% | +$88.5M | 0.17% | 103 |
|
2023
Q4 | $7.76B | Buy |
8,838,285
+39,780
| +0.5% | +$34.9M | 0.17% | 104 |
|
2023
Q3 | $7.24B | Sell |
8,798,505
-58,533
| -0.7% | -$48.2M | 0.18% | 96 |
|
2023
Q2 | $6.36B | Buy |
8,857,038
+4,917
| +0.1% | +$3.53M | 0.15% | 109 |
|
2023
Q1 | $7.27B | Buy |
8,852,121
+129,673
| +1% | +$107M | 0.19% | 95 |
|
2022
Q4 | $6.29B | Buy |
8,722,448
+74,323
| +0.9% | +$53.6M | 0.17% | 110 |
|
2022
Q3 | $5.96B | Buy |
8,648,125
+77,380
| +0.9% | +$53.3M | 0.18% | 100 |
|
2022
Q2 | $5.07B | Buy |
8,570,745
+210,415
| +3% | +$124M | 0.14% | 124 |
|
2022
Q1 | $5.84B | Buy |
8,360,330
+201,815
| +2% | +$141M | 0.14% | 122 |
|
2021
Q4 | $5.15B | Buy |
8,158,515
+87,234
| +1% | +$55.1M | 0.12% | 152 |
|
2021
Q3 | $4.88B | Buy |
8,071,281
+101,621
| +1% | +$61.5M | 0.12% | 144 |
|
2021
Q2 | $4.45B | Sell |
7,969,660
-30,752
| -0.4% | -$17.2M | 0.11% | 158 |
|
2021
Q1 | $3.79B | Buy |
8,000,412
+69,192
| +0.9% | +$32.7M | 0.1% | 174 |
|
2020
Q4 | $3.83B | Sell |
7,931,220
-57,008
| -0.7% | -$27.5M | 0.11% | 160 |
|
2020
Q3 | $4.47B | Buy |
7,988,228
+143,233
| +2% | +$80.2M | 0.15% | 117 |
|
2020
Q2 | $4.89B | Buy |
7,844,995
+1,429,765
| +22% | +$892M | 0.17% | 99 |
|
2020
Q1 | $3.13B | Buy |
6,415,230
+162,927
| +3% | +$79.6M | 0.13% | 143 |
|
2019
Q4 | $2.35B | Buy |
6,252,303
+47,835
| +0.8% | +$18M | 0.08% | 261 |
|
2019
Q3 | $1.72B | Buy |
6,204,468
+125,121
| +2% | +$34.7M | 0.06% | 338 |
|
2019
Q2 | $1.9B | Buy |
6,079,347
+54,247
| +0.9% | +$17M | 0.07% | 295 |
|
2019
Q1 | $2.47B | Buy |
6,025,100
+127,067
| +2% | +$52.2M | 0.1% | 203 |
|
2018
Q4 | $2.2B | Buy |
5,898,033
+143,106
| +2% | +$53.5M | 0.1% | 195 |
|
2018
Q3 | $2.33B | Buy |
5,754,927
+75,868
| +1% | +$30.7M | 0.09% | 213 |
|
2018
Q2 | $1.96B | Buy |
5,679,059
+71,435
| +1% | +$24.6M | 0.08% | 246 |
|
2018
Q1 | $1.93B | Buy |
5,607,624
+113,573
| +2% | +$39.1M | 0.08% | 241 |
|
2017
Q4 | $2.07B | Buy |
5,494,051
+94,540
| +2% | +$35.5M | 0.09% | 233 |
|
2017
Q3 | $2.41B | Buy |
5,399,511
+129,053
| +2% | +$57.7M | 0.11% | 179 |
|
2017
Q2 | $2.59B | Buy |
5,270,458
+148,962
| +3% | +$73.2M | 0.13% | 150 |
|
2017
Q1 | $1.98B | Buy |
5,121,496
+199,975
| +4% | +$77.5M | 0.1% | 197 |
|
2016
Q4 | $1.81B | Buy |
4,921,521
+110,090
| +2% | +$40.4M | 0.1% | 208 |
|
2016
Q3 | $1.93B | Buy |
4,811,431
+32,245
| +0.7% | +$13M | 0.11% | 178 |
|
2016
Q2 | $1.67B | Buy |
4,779,186
+92,467
| +2% | +$32.3M | 0.1% | 205 |
|
2016
Q1 | $1.69B | Buy |
4,686,719
+129,032
| +3% | +$46.5M | 0.11% | 186 |
|
2015
Q4 | $2.47B | Buy |
4,557,687
+131,565
| +3% | +$71.4M | 0.17% | 116 |
|
2015
Q3 | $2.06B | Buy |
4,426,122
+130,937
| +3% | +$60.9M | 0.15% | 126 |
|
2015
Q2 | $2.19B | Buy |
4,295,185
+108,784
| +3% | +$55.5M | 0.15% | 129 |
|
2015
Q1 | $1.89B | Buy |
4,186,401
+175,718
| +4% | +$79.3M | 0.13% | 158 |
|
2014
Q4 | $1.65B | Buy |
4,010,683
+151,130
| +4% | +$62M | 0.12% | 167 |
|
2014
Q3 | $1.39B | Sell |
3,859,553
-54,150
| -1% | -$19.5M | 0.11% | 182 |
|
2014
Q2 | $1.11B | Sell |
3,913,703
-1,186
| -0% | -$335K | 0.09% | 241 |
|
2014
Q1 | $1.18B | Buy |
3,914,889
+129,159
| +3% | +$38.8M | 0.1% | 212 |
|
2013
Q4 | $1.04B | Buy |
3,785,730
+91,460
| +2% | +$25.2M | 0.09% | 229 |
|
2013
Q3 | $1.16B | Sell |
3,694,270
-583,340
| -14% | -$183M | 0.11% | 172 |
|
2013
Q2 | $962M | Buy |
+4,277,610
| New | +$962M | 0.1% | 197 |
|